You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 3, March 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  BOOK REVIEWS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Impact of Randomized Clinical Trials on Health Policy and Medical Practice

Background Paper, Congress of the United States, Office of Technology Assessment, 109 pp, Washington, DC, US Government Printing Office, 1983, $5.

Israel A. Goldberg, PhD, Reviewer
Bethesda, Md

Arch Ophthalmol. 1985;103(3):332.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This concise background paper from the Office of Technology Assessment of the US Congress covers a number of topics that are of scientific and potentially economic significance to clinical researchers and practicing ophthalmologists.

First of all, this report, prepared by Hellen Gelband on the basis of a thorough literature review and interviews with many leading scientists and administrators in clinical research, is highly informative and provocative. She peppers the text with numerous interesting examples drawn from experiences with clinical trials, provides an excellent bibliography and a modest glossary, and includes material on related issues from numerous sources. Particularly noteworthy in this regard is her inclusion of a description of the "five behavioral pitfalls" that affect physicians' application of scientific findings to patient management (p 11), a clearly presented section on the role of randomized clinical trials in the regulation of drugs and devices (pp 31 ff), a review of the . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.